Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Antiangiogenic effects demonstrated for CA4P in mouse model of proliferative retinopathy

April 4, 2002

Sucampo licenses development and marketing rights to eye drop formulation of tacrolimus

April 2, 2002

ISTA reports preliminary phase III results for Vitrase

March 28, 2002

ISTA updates clinical progress of Vitrase

March 19, 2002

Inhibition of iNOS provides neuroprotection in glaucoma

March 11, 2002

Functional and morphological effects of Epitalon in rat model of retinitis pigmentosa

March 11, 2002

Russian research yields polypeptide complex with efficacy in exudative AMD

March 11, 2002

ISTA commences analysis of phase III Vitrase data

March 11, 2002

Allopurinol exerts immunomodulating effects in experimental autoimmune uveitis

March 8, 2002

Genentech defines MTD for antiangiogenic antibody fragment in AMD

March 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...